India to United States: Hydrocortisone Export Trade Route

The India to United States Hydrocortisone corridor is one of India's established pharmaceutical export routes, with 392 shipments documented worth a combined $12.6M USD. The route is dominated by STRIDES PHARMA SCIENCE LIMITED, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's hydrocortisone manufacturing sector.

Across 25 active suppliers, the average shipment value stands at $32.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 14.9%, placing it at rank #9 among India's top hydrocortisone export destinations globally.

On the import side, key buyers of Indian hydrocortisone in United States include STRIDES PHARMA INC, STRIDES PHARMA INC,, RISING PHARMA HOLDINGS, INC., and 111 others. STRIDES PHARMA INC is the single largest importer with 41 shipments valued at $6.1M USD.

India's hydrocortisone exports to United States are driven primarily by a handful of large-scale manufacturers. STRIDES PHARMA SCIENCE LIMITED with 61 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 25 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — STRIDES PHARMA SCIENCE LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, UMENDRA EXPORTS PRIVATE LIMITED — together account for 74% of total trade value on this route. The average shipment value of $32.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as hydrocortisone tablets usp 10mg 54 640 00x 100 s and neomycin and polymyxin b sulfates and hydrocortisone otic suspension, usp- rising pharma, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, STRIDES PHARMA INC is the largest importer with 41 shipments worth $6.1M USD — representing 49% of all hydrocortisone imports from India on this route. A total of 114 buyers are active on this corridor.